Koda, M., Imagama, S., Nakashima, H., Ito, S., Segi, N., Ouchida, J., . . . Yamazaki, M. Safety and feasibility of intravenous administration of a single dose of allogenic-Muse cells to treat human cervical traumatic spinal cord injury: A clinical trial. BMC.
Chicago Style (17th ed.) CitationKoda, Masao, et al. Safety and Feasibility of Intravenous Administration of a Single Dose of Allogenic-Muse Cells to Treat Human Cervical Traumatic Spinal Cord Injury: A Clinical Trial. BMC.
MLA (9th ed.) CitationKoda, Masao, et al. Safety and Feasibility of Intravenous Administration of a Single Dose of Allogenic-Muse Cells to Treat Human Cervical Traumatic Spinal Cord Injury: A Clinical Trial. BMC.
Warning: These citations may not always be 100% accurate.